McKesson is breaking out from a textbook volatility compression pattern. After a strong run higher in Q1, shares have formed a base with pullbacks shallowing from 12% to around 6% - a sign that sellers have been exhausted and supply is no longer coming to market. This will allow the stock to accelerate freely as demand increases for this stock.
Fundamentals look decent with steady earnings and sales growth. Additionally, the medical sector is showing strength in an otherwise weak market, and McKesson is a strong name to own in order to play that trend.
MCK broke out Monday on good volume above its resistance level. Traders can buy the stock here with a 7% stop to see if this move has legs.